Shelter Pharma Receives Positive Customer Feedback on Product Range
Shelter Pharma Limited announced on April 2, 2026, that its products are receiving encouraging and positive feedback from customers across the domestic market. The feedback highlights customer satisfaction with the quality, effectiveness, and overall experience of the company’s product range, including “FitKick Pro” and other offerings.Shelter Pharma, a GMP and ISO-certified manufacturer of Ayurvedic and herbal healthcare products for human and veterinary segments, believes this positive response may favorably impact its brand value and business growth. The company operates from Himatnagar, Gujarat, and has a legacy spanning over six decades with a portfolio of more than 300 formulations.
The company is sharing this information on a voluntary basis, noting it does not expect any immediate material impact on its financials.
Table: Details of Customer Feedback
| Sr. No. | Particulars | Details |
|---|---|---|
| 1 | Name of the Product / Segment | Company's Product Range (including 'FitKick Pro' and other products) |
| 2 | Nature of the Event | Receipt of positive customer feedback |
| 3 | Date of Occurrence | Ongoing (recent period) |
| 4 | Details of the Event | The Company has been receiving encouraging and positive feedback from customers across the domestic market for its product range. The feedback indicates customer satisfaction in terms of quality, effectiveness, and overall experience. |
| 5 | Impact on the Company | The Company believes that such positive feedback may have a favourable impact on brand value and future growth prospects. |
| 6 | Whether the event is material | The Company is sharing this information on a voluntary basis and does not expect any immediate material impact on its financials. |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.